ZOLEDRONIC ACID

25,636

Category Anti-Cancer
Generic ZOLONKO 4MG/5ML
Brand Name ZOLONKO
Company Name HIMMEL
Pack Size 1
Product Type INJECTION
Category:

Description

Zoledronic Acid – Bone-Strengthening Therapy for Cancer and Osteoporosis

Overview

Zoledronic Acid is a prescription medication used to treat and prevent bone-related conditions, particularly in patients with cancer or osteoporosis. It belongs to the bisphosphonate class of drugs and works by inhibiting bone resorption, strengthening bones, and reducing the risk of fractures. Zoledronic Acid is commonly used in patients with bone metastases from cancers such as breast, prostate, or multiple myeloma, as well as for managing osteoporosis in postmenopausal women.

Key Features / Indications

  • Active Ingredient: Zoledronic Acid
  • Therapeutic Class: Bisphosphonate / Bone-Modifying Agent
  • Indications:

o Bone metastases from breast, prostate, or other solid tumors

o Multiple myeloma-related bone disease

o Osteoporosis in postmenopausal women or men at high risk of fractures

  • Administration: Intravenous infusion under medical supervision, typically once yearly for osteoporosis or every 3–4 weeks for cancer-related bone disease
  • Mechanism of Action: Inhibits osteoclast activity, preventing bone breakdown and reducing skeletal complications
  • Benefits:

o Strengthens bones and reduces fracture risk

o Helps manage bone pain associated with metastases

o Supports long-term bone health in patients at risk of osteoporosis

o Convenient dosing schedule

Why Choose Oncomed Pharmacy?

Oncomed Pharmacy provides authentic, high-quality Zoledronic Acid with professional storage, handling, and delivery. Our pharmacists offer guidance on dosing schedules, administration, and monitoring for side effects to ensure safe and effective therapy. Choosing Oncomed Pharmacy guarantees reliable access to essential bone-modifying therapies with dedicated support throughout your treatment.

Uses of Medicine

Zoledronic Acid is primarily used for:

  • Preventing and treating bone complications from metastases in cancer patients
  • Managing multiple myeloma-related bone disease
  • Treating osteoporosis and reducing fracture risk in high-risk patients
  • Supporting overall bone health and strength

Reducing skeletal-related events such as fractures or spinal cord compression

Additional information

MG

100, 400

Reviews

There are no reviews yet.

Be the first to review “ZOLEDRONIC ACID”

Your email address will not be published. Required fields are marked *